Progesterone Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

The global market value of the progesterone market was USD 6.5 billion in 2022, and a CAGR of 13.4% is expected during the forecast period. Progesterone is a supportive hormone during pregnancy; excess use of it may cause damage to our body organs. It stimulates the production of GABA, which does help us in sleeping and in our mood swing. Rising disorders during pregnancy, increasing awareness about healthcare during pregnancy, endometrial cancer, menopause, and the large female population suffering from these diseases are driving the growth in the progesterone market. The rising prevalence of breast cancer is also growing this market significantly. This market is rapidly growing with time, but due to a lack of awareness, there is a slowdown in the market, which is overall harming market growth.

Impact of Covid-19

Due to the disruptions in the pharmaceutical supply chain, the shift in priorities, and changes in patient behavior, COVID-19 is negatively influencing this market. Fluctuations in healthcare utilization during the pandemic have influenced demand during the pandemic, production delays, and supply chain challenges have caused a significant slowdown in the progesterone market.

Growth Drivers

Growth drivers in the market include increasing awareness and adoption of hormone replacement therapy for various medical conditions, rising prevalence of hormonal disorders, expanding applications of progesterone in fertility treatments, increasing prevalence of breast cancer, an aging population, advancements in drug formulation and delivery methods, and a growing focus on women’s health all around the world, which is driving the growth in the market. Increasing expenditure on healthcare by the government is also driving the growth in the market.

As research and development continue to explore new therapeutic applications for progesterone, the market is expected to see further expansion. Initiatives taken by the government to increase awareness about female health in society are driving the growth of the market significantly. Rising demand for women's health solutions and increasing emphasis on women’s health, including hormone-related issues and reproductive health, are driving the growth of the market. Expanding applications in fertility treatment, contributing to the growth of the market as more individuals seek assisted reproductive technologies. Tailoring treatment to individual patient needs, including hormone therapy, is gaining prominence, boosting the demand for personalized progesterone-based interventions.

Supportive healthcare policies and initiatives aimed at addressing hormonal health issues are fostering market growth by encouraging research, development, and accessibility of progesterone-based medicine. Advancements in drug delivery methods, such as transdermal patches and sustained-release formulations, are improving the convenience and effectiveness of progesterone administration. Rising cases of hormonal disorders, such as polycystic ovary syndrome and endometriosis, are contributing to the growing demand for progesterone.

Segmentation

Type

·         Synthetic

·         Natural

Mode of Delivery

·         Injectable

·         Suspended

·         Oral

Application

·         Contraception

·         Endometrial Cancer

·         Dysfunctional Uterine Bleeding

·         Hyperplastic precursor lesions

·         Menopause

·         Others

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Europe

·         Middle East and Africa

Progesterone Market Type Segmentation

On the basis of type, the progesterone market is segmented into synthetic, and natural. Natural progesterone is derived from plant sources, often extracted from yarns, or soybeans. It is considered bioidentical because its molecular structure closely resembles the progesterone produced by the human body. It is usually obtained through a process of converting plant-derived pre-cursor into progesterone. It is commonly used hormone replacement therapy, and fertility treatments. It is available in prescription formulations as well as over the counter creams and supplements. Synthetic progesterone is chemically synthesized in a laboratory, and it is often derived from various steroidal compounds. Both are having same structure, but synthetic progesterone is slightly different from natural progesterone, making it non-bioidentical. it is usually obtained through a process of converting plant-derived pre-cursor into progesterone. It is commonly used hormone replacement therapy, and fertility treatments.

al. Synthetic progesterone is created through chemical processes. It is found in various pharmaceutical products, including contraceptives, hormone therapies, and medication for menstrual disorders. It is metabolized differently from natural progesterone, leading to a potential variation in effects, and side effects.

Progesterone Market Application Segmentation

On the basis of application, the progesterone market is segmented into contraception, menopause, endometrial cancer, dysfunctional uterine bleeding, hyperplastic precursor lesions, and others. The menopause segment is dominating and is expected to dominate during the forecast period. The increasing prevalence of hormonal disorders, aging population, and female health popularity are driving the growth in the market.

Regional Outlook

On the basis of the regions, the progesterone market is segmented into five parts: Asia Pacific, North America, and Latin America. Europe, the Middle East, and Africa. North America dominated the market in 2023 and is expected to dominate during the forecast period. The presence of major key players in the region, major product launches, and favorable reimbursement policies are driving the market in this region. North America boasts a well-established and advanced healthcare infrastructure, enabling efficient production, distribution, and access to progesterone-based medications.

The high prevalence of hormonal disorders, robust research and development activities in the pharmaceutical industry, and an aging population are driving the growth of the market. Europe maintains strict regulatory standards, ensuring the quality and safety of pharmaceutical products and fostering trust among consumers and healthcare professionals, which is contributing to the growth of the market. Growing awareness of women’s health issues, coupled with healthcare initiatives, promotes the adoption of progesterone-based therapies in Europe. Europe is home to several prominent pharmaceutical companies involved in hormonal therapies. The presence of key market players drives innovation and market expansion. Rising health expenditures in the Asia-Pacific region enhance infrastructure and healthcare services, facilitating better access to progesterone treatments.

Asia-Pacific countries, particularly India and Thailand, have become popular destinations for medical tourism. It includes hormonal treatments, further boosting the progesterone market. As awareness about women’s health and hormonal disorders rises in Asia-Pacific countries, there is a corresponding increase in the demand for progesterone-based treatments. The region’s large and growing population contributes to a substantial patient pool for hormonal therapies, including progesterone. As the prevalence of hormonal disorders increases, Increased healthcare spending in countries like India and China is facilitating better access to progesterone treatments.

Key players

·         Lupin Limited

·         Glenmark Pharmaceuticals

·         Cipla Limited

·         Alkem Labs

·         Cadila Pharmeceuticals

·         Mankind Pharma

·         Teva Pharmaceuticals

·         Estrellas Life

·         Sciences Limited

·         Blubell Pharma

·         BiON Pharma

·         Aquatic Remedies Limited

·         Sofgen Pharmaceuticals

·         Other Players